Although de novo KRAS or NRAS mutations were reported in MM patients at disease relapse, our findings indicate that it is possible to identify them even at diagnosis, if sequencing is performed on the CD138 population from BM [42]. This evidence concerns the gene SDC1 and Miyoshi myopathy.